A novel tumor-homing TRAIL variant eradicates tumor xenografts of refractory colorectal cancer cells in combination with tumor cell-targeted photodynamic therapy.

Saved in:
Bibliographic Details
Title: A novel tumor-homing TRAIL variant eradicates tumor xenografts of refractory colorectal cancer cells in combination with tumor cell-targeted photodynamic therapy.
Authors: Li Z; NHC Key Lab of Transplant Engineering and Immunology, West China Hospital, Sichuan University, Chengdu, China., She T; NHC Key Lab of Transplant Engineering and Immunology, West China Hospital, Sichuan University, Chengdu, China., Yang H; NHC Key Lab of Transplant Engineering and Immunology, West China Hospital, Sichuan University, Chengdu, China.; Sichuan Provincial Engineering Laboratory of Pathology in Clinical Application, West China Hospital, Sichuan University, Chengdu, China.; Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China., Su T; Laboratory of Clinical Proteomics and Metabolomics, Institutes for Systems Genetics, West China Hospital, Sichuan University, Chengdu, China., Shi Q; NHC Key Lab of Transplant Engineering and Immunology, West China Hospital, Sichuan University, Chengdu, China., Tao Z; NHC Key Lab of Transplant Engineering and Immunology, West China Hospital, Sichuan University, Chengdu, China.; Sichuan Provincial Engineering Laboratory of Pathology in Clinical Application, West China Hospital, Sichuan University, Chengdu, China.; Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China., Feng Y; NHC Key Lab of Transplant Engineering and Immunology, West China Hospital, Sichuan University, Chengdu, China., Yang F; NHC Key Lab of Transplant Engineering and Immunology, West China Hospital, Sichuan University, Chengdu, China., Cheng J; NHC Key Lab of Transplant Engineering and Immunology, West China Hospital, Sichuan University, Chengdu, China.; Sichuan Provincial Engineering Laboratory of Pathology in Clinical Application, West China Hospital, Sichuan University, Chengdu, China.; Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.; Laboratory of Clinical Proteomics and Metabolomics, Institutes for Systems Genetics, West China Hospital, Sichuan University, Chengdu, China., Lu X; NHC Key Lab of Transplant Engineering and Immunology, West China Hospital, Sichuan University, Chengdu, China.; Sichuan Provincial Engineering Laboratory of Pathology in Clinical Application, West China Hospital, Sichuan University, Chengdu, China.; Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Source: Drug delivery [Drug Deliv] 2022 Dec; Vol. 29 (1), pp. 1698-1711.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9417471 Publication Model: Print Cited Medium: Internet ISSN: 1521-0464 (Electronic) Linking ISSN: 10717544 NLM ISO Abbreviation: Drug Deliv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1521-0464
DOI:10.1080/10717544.2022.2079766